Bajaj Healthcare forges CDMO agreement with UK/EU clients for API supply

Pallavi Madhiraju- February 28, 2024 0

Bajaj Healthcare Ltd., a prominent figure in the pharmaceutical industry specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Formulations, has announced a ... Read More

Lupin Limited announces satisfactory FDA inspection results for Mandideep facility

Pallavi Madhiraju- November 1, 2023 0

Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for ... Read More

Aurobindo Pharma to acquire Sandoz US dermatology and oral solids divisions for $1bn

pallavi123- September 9, 2018 0

Aurobindo Pharma, a prominent Indian pharmaceutical company, has agreed to a significant acquisition from Sandoz US, a division of the Swiss pharmaceutical giant Novartis. The ... Read More

Avara Pharmaceutical expands into Canadian market with acquisition of sterile manufacturing facility

pharmanewsdaily- September 8, 2018 0

Avara Pharmaceutical Services, a prominent US-based contract development and manufacturing organization (CDMO), has successfully completed the acquisition of a sterile manufacturing facility for injectable medicines ... Read More

Olon acquires API manufacturing plant in Maharashtra, India to expand global footprint

pharmanewsdaily- September 5, 2018 0

Olon, a prominent developer and manufacturer of active pharmaceutical ingredients (API) based in Italy, has strategically expanded its global operations with the acquisition of a ... Read More

LEO Pharma secures global rights to JW1601 in $402m deal with JW Pharmaceutical

pharmanewsdaily- August 27, 2018 0

LEO Pharma, a leading Danish pharmaceutical company, has acquired global exclusive rights to the atopic dermatitis drug JW1601 from JW Pharmaceutical (JWP), in a significant ... Read More

Norgine expands presence in Germany with new office opening in Wettenberg

pharmanewsdaily- July 21, 2018 0

Dutch pharmaceutical giant Norgine has inaugurated new offices in Wettenberg, Germany, marking a significant step in its ongoing growth strategy. This move strengthens its commitment ... Read More

Sanofi to build new $396m vaccine manufacturing facility in Toronto

pallavi123- April 15, 2018 0

Significant Investment in Vaccine Production: French pharmaceutical giant Sanofi has announced plans to invest CAD 500 million (approximately $396.3 million) to construct a new vaccine ... Read More

Novartis to acquire AveXis for $8.7bn to expand gene therapy and neuroscience portfolio

pallavi123- April 9, 2018 0

Novartis, a Swiss pharmaceutical giant, has confirmed a substantial acquisition of AveXis, a US-based gene therapy company, for a total of $8.7 billion. This strategic ... Read More

GlaxoSmithKline to acquire full ownership of consumer healthcare venture from Novartis for $13bn

pallavi123- March 28, 2018 0

In a major strategic shift, GlaxoSmithKline (GSK) has finalized an agreement to acquire Novartis' 36.5% stake in their consumer healthcare joint venture for $13 billion. ... Read More